Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Penumbra Denmark ApS
APS
Active
CVR 43820702
Godthåbsvej 4
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
7 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 14,5M
+403% vs 2023
EBITDA margin
8.4%
+575% vs 2023
Equity ratio
22.8%
Financial strength
Net profit 2024
DKK 901K
+667% vs 2023
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
DKK 14,5M
+403%
EBITDA
DKK 1,2M
+575%
Net profit
DKK 901K
+667%
Total assets
DKK 4,7M
+445%
Equity
DKK 1,1M
+572%
Employees
7
—
Company information
Legal name
Penumbra Denmark ApS
CVR number
43820702
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. januar 2023
Share capital
DKK 41.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med distribution af medicinsk udstyr, samt hermed beslægtet virksomhed.
Contact
Address
Godthåbsvej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Silkeborg
All Denmark companies
Revenue
DKK millions
0M
4M
9M
13M
17M
3M
2023
15M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
2.882
14.510
Staff expenses
-2.701
-13.290
EBITDA
181
1.220
Depreciation & amort.
-0
-0
EBIT
181
1.220
Net financials
-0
-30
Profit before tax
181
1.190
Tax
63
289
Net profit
117
901
Balance sheet
DKK thousands
Item
2023
2024
Total assets
853
4.650
Equity
157
1.058
Long-term debt
0
0
Short-term debt
695
3.592
Total debt
695
3.592
Financial ratios
5-year trend
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
2023
2024
Equity ratio
22.8%
This company
38.2%
Market median
-40% vs market
2023
2024
Return on equity
85.1%
This company
18.4%
Market median
+362% vs market
2023
2024
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
2023
2024
Asset turnover
3.12×
This company
1.12×
Market median
+179% vs market
2023
2024
Debt / equity
3.39×
This company
0.62×
Market median
-447% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-31 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (5)
JS
Jasper Sökeland
Management
Management
2023
JK
Joan Kristensen
Management
Management
2023
JW
Johanna Williams Roberts
Management
Management
2025
AE
Adam Elsesser
Management
Management
2023
RM
Richard Michael O´Brien
Management
Management
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Penumbra, Inc.
Individual
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Penumbra Denmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jasper Sökeland
Management
0 companies
Joan Kristensen
Management
0 companies
Johanna Williams Roberts
Management
0 companies
Adam Elsesser
Management
0 companies
Richard Michael O´Brien
Management
0 companies